VIEMED HEALTHCARE INC (VMD) Stock Fundamental Analysis
NASDAQ:VMD - Nasdaq - CA92663R1055 - Common Stock - Currency: USD
VMD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 108 industry peers in the Health Care Providers & Services industry. While VMD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. VMD is growing strongly while it is still valued neutral. This is a good combination! These ratings could make VMD a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
In the past year VMD was profitable.
In the past year VMD had a positive cash flow from operations.
In the past 5 years VMD has always been profitable.
Each year in the past 5 years VMD had a positive operating cash flow.
1.2 Ratios
VMD has a better Return On Assets (6.15%) than 84.11% of its industry peers.
VMD has a better Return On Equity (8.34%) than 71.96% of its industry peers.
With a decent Return On Invested Capital value of 8.53%, VMD is doing good in the industry, outperforming 78.50% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for VMD is in line with the industry average of 8.14%.
The 3 year average ROIC (7.69%) for VMD is below the current ROIC(8.53%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.15% | ||
| ROE | 8.34% | ||
| ROIC | 8.53% |
ROA(3y)6.54%
ROA(5y)11.58%
ROE(3y)8.33%
ROE(5y)16.6%
ROIC(3y)7.69%
ROIC(5y)10.69%
1.3 Margins
With an excellent Profit Margin value of 4.87%, VMD belongs to the best of the industry, outperforming 81.31% of the companies in the same industry.
In the last couple of years the Profit Margin of VMD has declined.
Looking at the Operating Margin, with a value of 7.56%, VMD is in the better half of the industry, outperforming 74.77% of the companies in the same industry.
VMD's Operating Margin has declined in the last couple of years.
VMD's Gross Margin of 60.28% is amongst the best of the industry. VMD outperforms 80.37% of its industry peers.
In the last couple of years the Gross Margin of VMD has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.56% | ||
| PM (TTM) | 4.87% | ||
| GM | 60.28% |
OM growth 3Y-24.03%
OM growth 5Y-12.35%
PM growth 3Y-38.44%
PM growth 5Y-17.59%
GM growth 3Y0.34%
GM growth 5Y-3.62%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VMD is destroying value.
Compared to 1 year ago, VMD has more shares outstanding
Compared to 5 years ago, VMD has more shares outstanding
The debt/assets ratio for VMD is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 6.44 indicates that VMD is not in any danger for bankruptcy at the moment.
VMD's Altman-Z score of 6.44 is amongst the best of the industry. VMD outperforms 90.65% of its industry peers.
The Debt to FCF ratio of VMD is 1.86, which is an excellent value as it means it would take VMD, only 1.86 years of fcf income to pay off all of its debts.
VMD has a Debt to FCF ratio of 1.86. This is amongst the best in the industry. VMD outperforms 85.98% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that VMD is not too dependend on debt financing.
VMD has a better Debt to Equity ratio (0.05) than 79.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 1.86 | ||
| Altman-Z | 6.44 |
ROIC/WACC0.93
WACC9.13%
2.3 Liquidity
A Current Ratio of 1.31 indicates that VMD should not have too much problems paying its short term obligations.
VMD has a worse Current ratio (1.31) than 60.75% of its industry peers.
VMD has a Quick Ratio of 1.19. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.19, VMD is in line with its industry, outperforming 41.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.31 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 17.39% over the past year.
The Earnings Per Share has been growing slightly by 1.11% on average over the past years.
Looking at the last year, VMD shows a very strong growth in Revenue. The Revenue has grown by 26.22%.
VMD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.19% yearly.
EPS 1Y (TTM)17.39%
EPS 3Y-30.66%
EPS 5Y1.11%
EPS Q2Q%42.86%
Revenue 1Y (TTM)26.22%
Revenue growth 3Y11.7%
Revenue growth 5Y23.19%
Sales Q2Q%17.41%
3.2 Future
VMD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.41% yearly.
The Revenue is expected to grow by 16.35% on average over the next years. This is quite good.
EPS Next Y8.77%
EPS Next 2Y23.87%
EPS Next 3Y26.41%
EPS Next 5YN/A
Revenue Next Year22.78%
Revenue Next 2Y17.49%
Revenue Next 3Y16.35%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
VMD is valuated quite expensively with a Price/Earnings ratio of 28.81.
VMD's Price/Earnings is on the same level as the industry average.
VMD is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 29.62, which is the current average of the S&P500 Index.
VMD is valuated rather expensively with a Price/Forward Earnings ratio of 19.50.
66.36% of the companies in the same industry are more expensive than VMD, based on the Price/Forward Earnings ratio.
VMD's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.70.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.81 | ||
| Fwd PE | 19.5 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, VMD is valued cheaply inside the industry as 86.92% of the companies are valued more expensively.
VMD's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 86.34 | ||
| EV/EBITDA | 7.25 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VMD does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of VMD may justify a higher PE ratio.
A more expensive valuation may be justified as VMD's earnings are expected to grow with 26.41% in the coming years.
PEG (NY)3.29
PEG (5Y)25.86
EPS Next 2Y23.87%
EPS Next 3Y26.41%
5. Dividend
5.1 Amount
VMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.78
-0.19 (-2.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners69.39%
Inst Owner ChangeN/A
Ins Owners13.2%
Ins Owner Change19.19%
Market Cap302.95M
Analysts80
Price Target13.09 (68.25%)
Short Float %0.9%
Short Ratio2.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.7%
Min EPS beat(2)-43.42%
Max EPS beat(2)32.01%
EPS beat(4)1
Avg EPS beat(4)-16.43%
Min EPS beat(4)-43.42%
Max EPS beat(4)32.01%
EPS beat(8)3
Avg EPS beat(8)-7.32%
EPS beat(12)4
Avg EPS beat(12)-8.15%
EPS beat(16)6
Avg EPS beat(16)11.26%
Revenue beat(2)2
Avg Revenue beat(2)0.82%
Min Revenue beat(2)0.49%
Max Revenue beat(2)1.15%
Revenue beat(4)4
Avg Revenue beat(4)0.57%
Min Revenue beat(4)0.18%
Max Revenue beat(4)1.15%
Revenue beat(8)6
Avg Revenue beat(8)0.45%
Revenue beat(12)10
Avg Revenue beat(12)1.25%
Revenue beat(16)12
Avg Revenue beat(16)1.46%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5%
EPS NY rev (1m)0%
EPS NY rev (3m)16.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.81 | ||
| Fwd PE | 19.5 | ||
| P/S | 1.41 | ||
| P/FCF | 86.34 | ||
| P/OCF | 8.1 | ||
| P/B | 2.42 | ||
| P/tB | 3.33 | ||
| EV/EBITDA | 7.25 |
EPS(TTM)0.27
EY3.47%
EPS(NY)0.4
Fwd EY5.13%
FCF(TTM)0.09
FCFY1.16%
OCF(TTM)0.96
OCFY12.34%
SpS5.5
BVpS3.21
TBVpS2.34
PEG (NY)3.29
PEG (5Y)25.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.15% | ||
| ROE | 8.34% | ||
| ROCE | 12.18% | ||
| ROIC | 8.53% | ||
| ROICexc | 9.32% | ||
| ROICexgc | 12.92% | ||
| OM | 7.56% | ||
| PM (TTM) | 4.87% | ||
| GM | 60.28% | ||
| FCFM | 1.64% |
ROA(3y)6.54%
ROA(5y)11.58%
ROE(3y)8.33%
ROE(5y)16.6%
ROIC(3y)7.69%
ROIC(5y)10.69%
ROICexc(3y)9.56%
ROICexc(5y)14.54%
ROICexgc(3y)10.77%
ROICexgc(5y)15.26%
ROCE(3y)10.98%
ROCE(5y)15.27%
ROICexcg growth 3Y-23.37%
ROICexcg growth 5Y-15.25%
ROICexc growth 3Y-31.19%
ROICexc growth 5Y-20.55%
OM growth 3Y-24.03%
OM growth 5Y-12.35%
PM growth 3Y-38.44%
PM growth 5Y-17.59%
GM growth 3Y0.34%
GM growth 5Y-3.62%
F-Score7
Asset Turnover1.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 1.86 | ||
| Debt/EBITDA | 0.14 | ||
| Cap/Depr | 135.91% | ||
| Cap/Sales | 15.81% | ||
| Interest Coverage | 14.79 | ||
| Cash Conversion | 90.89% | ||
| Profit Quality | 33.66% | ||
| Current Ratio | 1.31 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 6.44 |
F-Score7
WACC9.13%
ROIC/WACC0.93
Cap/Depr(3y)146.8%
Cap/Depr(5y)157.15%
Cap/Sales(3y)15.87%
Cap/Sales(5y)14.84%
Profit Quality(3y)98.37%
Profit Quality(5y)86.44%
High Growth Momentum
Growth
EPS 1Y (TTM)17.39%
EPS 3Y-30.66%
EPS 5Y1.11%
EPS Q2Q%42.86%
EPS Next Y8.77%
EPS Next 2Y23.87%
EPS Next 3Y26.41%
EPS Next 5YN/A
Revenue 1Y (TTM)26.22%
Revenue growth 3Y11.7%
Revenue growth 5Y23.19%
Sales Q2Q%17.41%
Revenue Next Year22.78%
Revenue Next 2Y17.49%
Revenue Next 3Y16.35%
Revenue Next 5YN/A
EBIT growth 1Y23.44%
EBIT growth 3Y-15.13%
EBIT growth 5Y7.98%
EBIT Next Year254.14%
EBIT Next 3Y65.22%
EBIT Next 5YN/A
FCF growth 1Y-25.66%
FCF growth 3Y-4.67%
FCF growth 5Y3.29%
OCF growth 1Y30.21%
OCF growth 3Y8.79%
OCF growth 5Y15.11%